Shutong Xu

509 citations
15 papers · 313 indexed · h-index 10
Topics
RNA modifications and cancer (4 papers)Epigenetics and DNA Methylation (3 papers)Cell Adhesion Molecules Research (3 papers)

In The Last Decade

Shutong Xu

14 papers receiving 308 citations

Peers

Shutong Xu
Comparison fields: 5 of 65
  • Molecular Biology 225
  • Immunology 48
  • Epidemiology 33
  • Immunology and Allergy 23
  • Plant Science 22
Replace Paula Portela with:
Paula Portela Argentina
Alexia Carré France
Samuel C. Griffiths United Kingdom
H. Kim South Korea
M. Katar United States
Kyoko Kojima‐Aikawa Japan
Li Phing Liew United Kingdom
Yuqi Zhu China
Jeong Hyun Ahn United States
Fiana Levitin Israel
Shutong Xu relative to Paula Portela Argentina Paula Portela's profile →
Citations per field
00.5×1.5×2.1×
Paula Portela · 1×
Citations per year

Countries citing papers authored by Shutong Xu

Since Specialization
Citations

This map shows the geographic impact of Shutong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shutong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shutong Xu more than expected).

Fields of papers citing papers by Shutong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shutong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shutong Xu. The network helps show where Shutong Xu may publish in the future.

Co-authorship network of co-authors of Shutong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shutong Xu. A scholar is included among the top collaborators of Shutong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shutong Xu. Shutong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 8
2 3
3 6
4 11
5 2
6 29
7 12
8 39
9 36
10 25
11
Distinct recognition of complement iC3b by integrins .ALPHA.X.BETA.2 and .ALPHA.M.BETA.2
0
12 46
13 9
14 60
15 27

About Shutong Xu

Shutong Xu is a scholar working on Immunology and Allergy, Molecular Biology and Biochemistry, having authored 15 papers that have together received 313 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Immunology and Allergy (23 citations), Molecular Biology (225 citations) and Immunology (48 citations). Shutong Xu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Jianping Ding, Chen Zhong, Timothy A. Springer, Jia‐Huai Wang, Bingfa Sun, Jian Wu, Jianchuan Wang, Tianlong Zhang, Rong Wang and Chafen Lu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026